Genetically predicted obstructive sleep apnea liability associated with increased myocardial infarction risk in Mendelian randomization analysis
This Mendelian randomization analysis evaluated the causal relationship between genetically predicted liability to obstructive sleep apnea (OSA) and the risk of myocardial infarction (MI). The study utilized genetic instruments to assess OSA liability, finding an odds ratio of 1.0024 per log-OR increase in liability (95% CI: 1.0010-1.0039; P=0.001). This suggests a potential causal link, though the effect size per unit increase is very small.
mediation analysis revealed that body mass index (BMI) was the strongest mediator, explaining 35.94% of the observed association (P=0.030). In contrast, systolic blood pressure showed minimal mediation, accounting for only 0.28% of the association (P=0.678). When the model was adjusted for both BMI and systolic blood pressure, the direct association between OSA and MI was attenuated, with a P-value of 0.156.
Further modeling including atrial fibrillation demonstrated that OSA had only a marginal direct effect (P=0.050), whereas atrial fibrillation remained independently associated with MI (P=0.004). The analysis also found no evidence that MI influenced OSA risk, ruling out reverse causality. Safety data, adverse events, and discontinuations were not reported. The study limitations include the inherent constraints of Mendelian randomization designs and the attenuation of the primary association after accounting for established cardiometabolic risk factors like obesity and hypertension.